The 20 Best Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Doctors Near Me in Baltimore, MD

Elias Sotirchos, M.D., specializes in the diagnosis, management and treatment of neuroimmunological disorders that involve the central nervous system, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). His research focuses on developing and validating novel imaging and blood-based biomarkers of these conditions, and clinical trials of experimental therapeutic agents. Dr. Sotirchos earned his medical degree from the National and Kapodistrian University of Athens and subsequently completed his internship and neurology residency training at The Johns Hopkins Hospital. He then pursued advanced clinical and research training in neuroimmunology at Johns Hopkins as a National MS Society Sylvia Lawry Fellow. Dr. Sotirchos is rated as a Distinguished provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Multiple Sclerosis (MS), Neuromyelitis Optica, and Transverse Myelitis. Dr. Sotirchos is board certified in American Board Of Psychiatry And Neurology.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as a Distinguished provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis. Dr. Banwell is board certified in Royal College Of Physicians And Surgeons Of Canada.

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Advanced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS). Dr. Newsome is board certified in American Board Of Psychiatry And Neurology.

Bardia Nourbakhsh, M.D., M.A.S., is an associate professor of neurology at Johns Hopkins University School of Medicine. He practices out of The Johns Hopkins Hospital in Baltimore, Maryland. Dr. Nourbakhsh has expertise in multiple sclerosis (MS) and neuroimmunology. Dr. Nourbakhsh earned his medical degree from the Tehran University School of Medical Sciences and completed a residency in neurology at the University of Texas Southwestern Medical Center. He studied epidemiology, study design, and biostatistics, obtaining a Master of Advanced Studies degree in clinical research from the University of California, San Francisco School of Medicine, where he also completed a fellowship in MS and neuroimmunology. In 2014, Dr. Nourbakhsh earned the American Brain Foundation Clinical Research Training Fellowship in MS, the National Multiple Sclerosis Society Sylvia Lawry Clinical Research Fellowship, the Fred Baskin Young Investigator Award, and the Teva Neuroscience Award for Academic Excellence. In 2022, he was named a Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis Society. Dr. Nourbakhsh's research training focused on the design and execution of clinical trials and the use of biomarkers in MS. His current research interests include the comparative effectiveness studies of symptomatic and disease-modifying therapies in MS, as well as identifying new pathophysiologic mechanisms and therapeutic targets for MS-related fatigue. Dr. Nourbakhsh is the principal investigator of a randomized, double-blind clinical trial funded by the Department of Defense, which tests whether ketamine could be a treatment for MS fatigue. He has contributed to numerous publications, journal articles, abstracts and posters, and lectures. He is an ad hoc reviewer for Lancet Neurology, Annals of Neurology, Neurology, Neurology: Neuroimmunology and Neuroinflammation, Multiple Sclerosis Journal, and other journals. Dr. Nourbakhsh is rated as an Advanced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Meningocele. Dr. Nourbakhsh is board certified in American Board Of Psychiatry And Neurology.

Haiwen Chen is a pediatric neurologist who specializes in caring for children with pediatric onset neuroinflammatory and neuroinfectious diseases, including myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, multiple sclerosis, acute disseminated encephalomyelitis, optic neuritis, encephalitis and myelitis. After earning medical and postdoctoral degrees from the University of Maryland School of Medicine, Dr. Chen completed an internship and residency in pediatrics at The Johns Hopkins Hospital, where she remained and completed a pediatric neurology residency. She is fellowship trained in neuroimmunology and neurological infectious disease. Dr. Chen’s postdoctoral research studied synaptic structure and function using molecular biology and microscopy techniques. Her current research focuses on understanding the synaptic and immune mechanisms underlying the development of neuroimmune diseases, with the goal of identifying novel biomarkers for disease and potential targets for therapeutics. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Her clinical expertise encompasses Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Optic Neuritis, and Subdural Hematoma. Dr. Chen is board certified in American Board Of Psychiatry And Neurology.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy. Dr. Pardo is board certified in American Board Of Psychiatry And Neurology.

Dr. Kornberg completed his undergraduate studies at Yale University. He then received M.D. and Ph.D. degrees from the Johns Hopkins School of Medicine and stayed at Johns Hopkins for neurology residency and a clinical and research fellowship in neuroimmunology. He is committed to a career that combines the competent and compassionate care of patients with multiple sclerosis and other immunolgic disorders of the nervous system with basic and translational research aimed at developing improved therapies. Dr. Kornberg is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, Optic Neuritis, and Microvascular Decompression.

Dr. Bhargava developed an interest in immunology early in medical school at the Christian Medical College in Vellore, India. He then completed his neurology training at the Southern Illinois University School of Medicine and while there began research in the field of multiple sclerosis (MS). Following his neurology training he completed a 3-year fellowship at the Johns Hopkins University in neuroimmunology and neurological infections focusing on MS clinical care and research. His fellowship training was supported by a Sylvia Lawry physician fellowship award from the National MS Society. His main research interests include studying the role of inflammation in the meninges in progression of MS disease. He is currently involved in a trial testing the utility of injecting a drug called rituximab into the spinal fluid in patients with progressive MS. He is also developing an animal model of the process of meningeal inflammation to test other potential treatments. This work is supported by awards from the National MS Society, Race to Erase MS and the American Academy of Neurology. He is also actively involved in studying the role of measuring lipids and small molecule metabolites in serum and plasma to help identify new biomarkers for improved diagnosis and prognosis of the disease. These methods could also help in better tracking the effects of various interventions and in personalizing the treatment of patients with MS. Dr. Bhargava is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, and Transverse Myelitis. Dr. Bhargava is board certified in American Board Of Psychiatry And Neurology.

Dr. Mowry became interested in multiple sclerosis (MS) prior to beginning college and first performed MS research as an undergraduate biology major at Georgetown University. As a neurology resident at the University of Pennsylvania, she began her multiple sclerosis clinical research activities in conducting a study of visual dysfunction and quality of life in multiple sclerosis. During her fellowship at UCSF, Dr. Mowry evaluated prognostic factors in multiple sclerosis and examined health-related quality of life in multiple sclerosis, particularly as a marker of disease burden. She also earned a Master’s Degree in Clinical Research at UCSF. Dr. Mowry continued as a member of the faculty there before joining the Johns Hopkins Department of Neurology as an Assistant Professor in July, 2011; she received a joint appointment in Epidemiology in 2013. She was appointed as the inaugural Richard T. and Frances W. Johnson Professor in 2022. Over the past several years, Dr. Mowry has worked primarily to perform epidemiologic investigations of multiple sclerosis (MS) risk and prognostic factors and has evaluated both genetic and environmental contributors. While she has had a major role in several such studies, her most significant work led to the identification of the association of vitamin D status with relapse and brain lesion risk in patients with MS (Annals of Neurology 2010, Annals of Neurology 2012, European Journal of Neurology 2015). She also conducted the first pilot study comparing gut bacterial populations in patients with MS and healthy individuals (Journal of Investigative Medicine 2014). She was recently funded to investigate the impact of vitamin D supplementation on the metabolomics profile in patients with MS compared to healthy controls. She enjoys designing and conducting clinical trials in MS and is the Principal Investigator of the Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) multicenter vitamin D trial (NCT01490502), which is sponsored by the National MS Society and a smaller multicenter pilot study investigating vitamin D pharmacokinetics in MS patients and healthy controls (NCT01667796). She is also the recipient of a Harry Weaver Award from the National MS Society, in which she is investigating the impact of intermittent calorie restriction in MS. Finally, as Director of the MS Experimental Therapeutics Program at Johns Hopkins, she assists colleagues with study design and helps oversee the conduct of MS clinical trials. Dr. Mowry is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Neuromyelitis Optica. Dr. Mowry is board certified in American Board Of Psychiatry And Neurology.

Dr. Justin McArthur is nationally and internationally recognized for his work in studying the natural history, development and treatment of the neurological complications of HIV/AIDS, multiple sclerosis and other neurological infections and immune-mediated neurological disorders. Dr. McArthur has also developed a technique to use cutaneous nerves to study sensory neuropathies, including those associated with chemotherapy, HIV and diabetes. Currently his clinical practice includes neuroimmunological disorders including MS, neurological infections, and complex undiagnosed neurological disorders. Dr. McArthur was the founding director of the Johns Hopkins/National Institute of Mental Health Research Center for HIV-associated Cognitive Disorders. The Center is an experienced interdisciplinary research team who have pooled their talents to study the nature of HIV-associated cognitive disorders. he is also the founding director of the Johns Hopkins Sheikh Khalifa Stroke institute. Dr. McArthur received his medical degree from Guys Hospital Medical School in London, UK. He then completed an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, MD. Dr. McArthur stayed with Johns Hopkins to complete a residency in neurology and achieve his Master's in public health. He is the current Director of the Johns Hopkins Department of Neurology and holds the John W. Griffin Professorship in neurology which was established in 2015 by Jeffrey and Harriet Legum. In April 2017 Dr. McArthur was elected to the Association of American Physicians. In 2020 he was inducted into the National Academy of Medicine. Dr. Mcarthur is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Progressive Multifocal Leukoencephalopathy, Relapsing Multiple Sclerosis (RMS), and Encephalitis. Dr. Mcarthur is board certified in American Board Of Psychiatry And Neurology and American Board Of Internal Medicine.

Preeti Raghavan, M.B.B.S., is a rehabilitation physician specializing in stroke rehabilitation. Dr. Raghavan is the director of the Center of Excellence in Stroke Treatment, Recovery and Rehabilitation at the Sheikh Khalifa Stroke Institute, as well as the Sheikh Khalifa Stroke Institute Professor of Stroke Treatment, Recovery and Rehabilitation. She uses innovative approaches to rehabilitation from stroke and other brain injuries and holds several patents for new technologies to support stroke recovery. Dr. Raghavan is an associate professor of physical medicine and rehabilitation in the Johns Hopkins Department of Physical Medicine and Rehabilitation, where she also serves as a vice chair for research. She completed a research fellowship in motor control and learning at Columbia University after a physical medicine and rehabilitation residency at Albert Einstein College of Medicine. Her research interests include the recovery of arm and hand function after brain injury, treatment of muscle stiffness, improving access to cost-effective stroke rehabilitation and investigating how emotional regulation interacts with recovery. Dr. Raghavan is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Hemiplegia, Athetosis, Myotonia Congenita, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Dr. Raghavan is board certified in American Board Of Physical Medicine And Rehabilitation.

Dr. Haris Sair is Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, and the Director of the Division of Neuroradiology. His areas of clinical expertise include functional Magnetic Resonance Imaging (fMRI) of the brain. He also has a faculty appointment in the Malone Center for Engineering in Healthcare at The Whiting School of Engineering, Johns Hopkins University, investigating the use of machine learning and artificial intelligence in imaging. He is a founding director of the Radiology Artificial Intelligence Lab (RAIL). He previously served as the President of the American Society of Functional Neuroradiology. Dr. Sair earned his M.D. from Duke University School of Medicine. He completed his Radiology residency at Temple University Medical Center, and fellowship in Neuroradiology at Massachusetts General Hospital in Boston, MA. Dr. Sair is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Normal Pressure Hydrocephalus, Traumatic Brain Injury, Cerebrospinal Fluid Leak, and Microvascular Decompression. Dr. Sair is board certified in American Board Of Radiology.

Dr. Angeliki Filippatou specializes in the diagnosis, management and treatment of neuroimmunological disorders with a particular focus on multiple sclerosis (MS). Her research focuses on the development of innovative prognostic and monitoring biomarkers for MS and related neuroimmunological conditions, including the integration of emerging digital health tools into disease tracking. Dr. Filippatou earned her medical degree from the National and Kapodistrian University of Athens, Greece and went on to complete her neurology residency at the Johns Hopkins Hospital. She pursued subspecialty fellowship training in neuroimmunology at Johns Hopkins. Her fellowship training was supported by the National Institutes of Health/ National Institute of Neurological Disorders and Stroke and the National MS Society. Dr. Filippatou is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Optic Neuritis, Multiple Sclerosis (MS), Neuromyelitis Optica, Transverse Myelitis, and Thrombectomy. Dr. Filippatou is board certified in American Board Of Psychiatry And Neurology.

Peter Jin is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Jin is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), and Gastrostomy.

Peter Calabresi is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Calabresi is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome.

Sarah Fredrich is a Neurologist practicing medicine in Baltimore, Maryland. She has been practicing medicine for over 10 years. Dr. Fredrich is rated as an Advanced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Encephalitis.

Haopeng Zheng is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Zheng is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Migraine, Headache, Memory Loss, and Increased Intracranial Pressure.

Daniel Harrison is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Harrison is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Gastrostomy.

David Benavides is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Benavides is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Anti-NMDA Receptor Encephalitis, Encephalitis, Multiple Sclerosis (MS), and Relapsing Multiple Sclerosis (RMS).

Deanna Saylor is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Saylor is rated as an Experienced provider by MediFind in the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Syphilitic Aseptic Meningitis, Multiple Sclerosis (MS), Headache, and Stroke.